Drug Approval | July 26, 2024
Sun Pharmaceutical receives USFDA approval for oral JAK inhibitor ‘Leqselvi’
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
ProtocolCopilot leverages advanced artificial intelligence to streamline the process of understanding and adhering to clinical research protocols
Ibara will drive AI-powered clinical research innovation
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
Merck shared updates on the company’s oncology pipeline and focused R&D approach
Acceptance based on results demonstrated a statistically significant improvement in overall survival versus chemotherapy alone in these patients
Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
The collaboration aims to bolster healthcare entrepreneurship
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
Subscribe To Our Newsletter & Stay Updated
